Review article: Prevention of stress-related mucosal bleeding with proton-pump inhibitors

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 22, Issue 3, 2005, Pages 45-52

  Maton, P N ^a,b  

^a Digestive Disease Research Institute   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; STOMACH SECRETION INHIBITOR; SUCRALFATE;

ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; IMMEDIATE RELEASE FORMULATION; INTENSIVE CARE UNIT; MORTALITY; MUCOSAL BLEEDING; PNEUMONIA; PRIORITY JOURNAL; REVIEW; STOMACH PH; STOMACH TUBE; STRESS;

EID: 28944431895     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02713.x     Document Type: Review

References (27)

1. Goldin GF, Peura DA. Stress-related mucosal damage. What to do or not to do. Gastrointest Endosc Clin N Am 1996; 6: 505-26.
2. Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest 2001; 119: 1222-41.
3. Cook DJ, Witt LG, Cook RJ, Guyatt GH. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med 1991; 91: 519-27.
4. Heyland D, Gafni A, Griffith L, et al. The clinical and economic consequences of clinically important gastrointestinal bleeding in critically ill patients. Clin Intensive Care 1996; 7: 121-5.
5. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330: 377-81.
6. Cook D, Heyland D, Griffith L, et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med 1999; 27: 2812-7.
7. Shuman RB, Schuster DP, Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med 1987; 106: 562-7.
8. Wilcox CM, Spenney JG. Stress ulcer prophylaxis in medical patients: who, what, and how much? Am J Gastroenterol 1988; 83: 1199-211.
9. Martin LF, Booth FV, Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med 1993; 21: 19-30.
10. Somberg L, Karlstadt R, Blatcher D, et al. Intermittent intravenous pantoprazole (P) maintains control of gastric pH in intensive care unit patients [Abstract]. Am J Gastroenterol 2002; 97(Suppl): S47.
11. Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005; 33: 760-5.
12. Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 2004; 26: 197-213.
13. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998; 338: 791-7.
14. Vorder Bruegge WF, Peura DA. Stress-related mucosal damage: review of drug therapy. J Clin Gastroenterol 1990; 12(Suppl 2): S35-40.
15. Atherton ST, White DJ. Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet 1978; 2: 968-9.
16. du Moulin GC, Paterson DG, Hedley-Whyte J, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982; 1: 242-5.
17. Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133: 792-6.
18. Messori A, Trippoli S, Vaiani M, Gorini M, Corrado A. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 2000; 321: 1103-6.
19. Mallow S, Ahern J. Nosocomial pneumonia and related complications in the critically ill trauma patient: does choice of proton pump inhibitor versus histamine antagonist influence infection? Crit Care Med 2002; 30: A118. [Abstract].
20. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003; 54: 243-5.
21. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004; 171: 33-8.
22. Louie TJ, Meddings J. Clostridium difficile infection in hospitals: risk factors and responses. CMAJ 2004; 171: 45-6.
23. Balaban DH, Duckworth CW, Peura DA. Nasogastric omeprazole: effects on gastric pH in critically ill patients. Am J Gastroenterol 1997; 92: 79-83.
24. Roberts K, Pitcher W, Cryer B. Effects of lansoprazole suspension versus continuous intravenous ranitidine infusion on gastric pH of mechanically ventilated intensive care unit patients [Abstract]. Pharmacother 2000; 20: 342.
25. Levy MJ, Seelig CB, Robinson NJ, Ranney JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997; 42: 1255-9.
26. Fink M, Karlstadt R, Maroko R, Field B. Intravenous pantoprazole (IVP) and continuous infusion cimetidine (C) prevent upper gastrointestinal bleeding (UGIB) regardless of ApS11 score (APACHE II) in high risk intensive care unit (ICU) patients [Abstract]. Gastroenterology 2003; 124: A625.
27. Hepburn B, Hardiman Y, Frank W, Goldlust B. A loading-dose regimen of omeprazole immediate-release oral suspension increases bioavailability (healthy subjects) and achieves rapid control of gastric acidity in critically ill. Gastroenterology 2004; 126: A192 [Abstract].